Exabis Library
Welcome to the e-CCO Library!
P018: Macrophage targeting contributes to the inhibitory effects of dihydroartemisinin on DSS-induced colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P018: Myeloid diversity in inflammatory bowel disease revealed by single-cell transcriptomics
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P018: Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P018: Should NUDT genotyping be tested routinely prior to commencement of thiopurine therapy in Asian patients?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P019 Colonic mucosal kinase activity, cytokine and chemokine profiles in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0190: Hypoglycemia induces SLC7A11-dependent disulfidptosis to regulate intestinal inflammation in IBD
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0191: The role of myeloid mineralocorticoid receptor and its target neutrophil gelatinase-associated lipocalin in mice with colitis.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0192: Activities of Sorghum bicolor diet on microbial gut-brain axis during experimental Crohn’s Colitis in adult male Wistar rats.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0193: Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0194: Osteoporosis and osteopenia as extraintestinal manifestations in ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0195: Immune reconstitution following autologous hematopoietic stem cell transplantation with cyclophosphamide-free mobilization for refractory Crohn’s disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0196: Metabolic dysregulation in Crohn’s disease fibrosis: Targeting WISP1 to restore ECM homeostasis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0197: Comparison of pharmacodynamic and mechanistic response of guselkumab intravenous and subcutaneous induction in moderately to severely active Crohn’s disease: molecular analysis of the GRAVITI and GALAXI Phase 3 studies
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0198: Comparative Transcriptomic Analysis of Tonsil-derived and Adipose-derived Mesenchymal Stem Cells: Proliferationx7x7x7 Migrationx7x7x7 and Anti-inflammatory Potential in Murine Colitis Model
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0199: Development of a high-throughput multiplex immunofluorescence and an AI-assisted image analysis tool to study T cells dynamics in pre-clinical rodent models of IBD
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P019: Anti-TNF-alpha therapy induces microbial and immunological changes in dextran sodium sulphate chronic colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P019: Differential effects of first-line IFX and conventional treatment on inflammatory serum proteins of paediatric moderate- to-severe Crohn’s disease patients.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P019: GS-1069518 is a potent and selective small molecule α4β7 inhibitor
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P019: Host-Enterobacteriaceae interactions and mitochondrial dysfunction in Crohn's colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P019: Informing ulcerative colitis pathophysiology and outcomes through metabolic pofiling
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM